Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) - Global Forecast to 2028

Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) - Global Forecast to 2028

The point of care diagnostics market is epected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion at a CAGR of 9.4% during the forecast period (2023–2028).The gobal rising burden of various helath conditions including diabetes, cardiovascular diseases, infectious diseases and the growing demand for early detection and monitoring of these of these diseases are likely to boost the adoption of PoC tetsing devices. Additionally, technological adcamcements, hleathacre policies promoting decentralized testing and emergence of small PoC manufacturers in emerging countries are likely to booost the growth of market during the forecast period.

“Infectious disease testing products segment of point of care diagnostics market to grow with the highest CAGR in the forecast period.”

Based on products, the infectious disease tetsing products segemnet is anticipated to grow at a signficant rate during the forecast period.Increasing number of infectious disease such as HIV, tuberculosis, respiratory infections, coupled with the growing availability & awareness of POC testing for infectious diseases are likely to prope the segment growth

“The clinical laboratories segment captired the largest market share of point of care diagnostics market in 2022”

On the basis of end users, the point-of-care and rapid diagnostics market is segmented into clinical laboratories; ambulatory care facilities and physicians’ offices; pharmacies, retail clinics, and E-commerce platforms; hospitals, critical care centers, and urgent care centers; home care & self-testing; and other end users.

Clinical laboratories are the primary end users of point-of-care testing a they handle hgh volume of testing, accelerating the demand for point of care diagnostics devices.Moreover, the rapid exoansion of clinical laboratories and presence of advanced PoC products in cinical laboratory settings are likely to promote the growth of the segment

North America accounted for the largest share of the point of care diagnostics market by region.

The global rpoint of care diagnostics market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for PoC products and services , whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The largest share of North America can be attributed to the rapid adoption of advanced diagnostic technologies, increases collaboration among rapid kits manufacturers and healthacre facilities, favorable reimbursement models, and well established healthacre infrastructure

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%

By Designation: C-level–10%, Director-level–14%, and Others–76%

By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%

The major players operating in the point-of-care diagnostics market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), and Becton, Dickinson and Company (US), QuidelOrtho Corporation (US), Chembio Diagnostics, Inc. (US), EKF Diagnostics Holdings plc)

Research Coverage

This report studies the point-of-care diagnostics market based on product, platform, mode of purchase, sample, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Analayis of Key divers (rising prevalnce of infectious and chronic disease, growing adoption of self tetssing kits, helathacre decentralization, rising number of CLIA-wavier Poc Tests), restriants (rising pricing pressure on PoC manufactures, stringent regulatory approval procedures for new PoC devices), Opportunities (emerging markets, emerging technologies, sucha s mucrofuidics) , Challenge (Training & education in low resource countries)

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the point-of-care diagnostics market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the point-of-care diagnostics market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the point-of-care diagnostics market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.